Yunsheng Yang, J. Fang, Xiaozhong Guo
May 1, 2018
Citations
2
Influential Citations
33
Citations
Quality indicators
Journal
Journal of Gastroenterology and Hepatology
Abstract
Linaclotide is a guanylate cyclase‐C agonist approved in multiple countries to treat irritable bowel syndrome with constipation (IBS‐C). China has unmet need for well‐tolerated therapy that is effective in treating both bowel and abdominal symptoms of IBS‐C. This trial evaluated linaclotide's efficacy and safety in IBS‐C patients in China and other regions.